微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Borrelia burgdorferi Johnson et al. emend. Baranton et al. |
|---|---|
| 商品货号： | TS167644 |
| Strain Designations： | HB19M |
| Application： | Used to produce vaccine against Lyme disease Emerging infectious disease research Vector borne research |
| Isolation： | Blood - human Belgium |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | frozen |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Comments： | Flagella-less mutant |
| Growth Conditions： | Temperature: 37.0°C Atmosphere: Aerobic |
| Name of Depositor： | AG Barbour |
| U.S. Patent Number： | |
| References： | Barbour AG, Bundoc V. Flagella-less borrelia. US Patent 5,436,000 dated Jul 25 1995 human blood |